SHELBY TRUE: Open Payments
NPI 1124745112 · RICHMOND, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$949 in 68 payments from 15 companies in 2025. Trend: 2023 $583 · 2024 $811 · 2025 $949
Food & beverage: $854Education: $95
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 28 | $300 |
| Vanda Pharmaceuticals Inc. | 17 | $243 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $69 |
| PFIZER INC. | 3 | $59 |
| Indivior Inc. | 3 | $49 |
| Gilead Sciences, Inc. | 2 | $42 |
| Otsuka America Pharmaceutical, Inc. | 2 | $38 |
| Lundbeck LLC | 2 | $35 |
| Teva Pharmaceuticals USA, Inc. | 1 | $24 |
| Corium, LLC | 1 | $21 |
Products named: FANAPT, VRAYLAR, QULIPTA, REXULTI, CAPLYTA, NURTEC ODT, SUBLOCADE, UBRELVY.
Industry payments across IN — which companies pay providers there.
